Roche Holding AG (Roche Holding AG) Gross-Profit-to-Asset % : 49.91% (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Roche Holding AG Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Roche Holding AG's annualized Gross Profit for the quarter that ended in Dec. 2023 was $49,489 Mil. Roche Holding AG's average Total Assets over the quarter that ended in Dec. 2023 was $99,157 Mil. Therefore, Roche Holding AG's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 49.91%.

Roche Holding AG Gross-Profit-to-Asset % Historical Data

The historical data trend for Roche Holding AG's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roche Holding AG Gross-Profit-to-Asset % Chart

Roche Holding AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

53.60

52.27

47.52

50.77

51.17

Roche Holding AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															47.24	52.68	50.97	53.51	49.91

Competitive Comparison of Roche Holding AG's Gross-Profit-to-Asset %

For the Drug Manufacturers - General subindustry, Roche Holding AG's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Roche Holding AG's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Roche Holding AG's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Roche Holding AG's Gross-Profit-to-Asset % falls into.

Roche Holding AG Gross-Profit-to-Asset % Calculation

Roche Holding AG's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	50975.948	/	( (94623.229	+	104611.471)	/ 2 )
	=	50975.948	/	99617.35
	=	51.17 %

Roche Holding AG's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	49488.9	/	( (93702.799	+	104611.471)	/ 2 )
	=	49488.9	/	99157.135
	=	49.91 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Roche Holding AG Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Roche Holding AG's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Roche Holding AG (Roche Holding AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (OTCPK:RHHBY) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

RHHVF:USA RHHBF:USA ROG N:Mexico ROz:UK ROGz:UK 0QOK:UK RHO6:Germany ROG:Switzerland RO:Switzerland

Address

Grenzacherstrasse 124, Basel, CHE, 4070

Website

https://www.roche.com

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.